Comprehensive Clinical Development, formerly operating as Comprehensive NeuroScience, Inc., announced today the acquisition of Charles River Clinical Services Northwest, Inc., including its 250-bed, 77,000-square-foot, Phase I-IIa facility located in Tacoma, Washington.
The increased capacity and capabilities deliver numerous benefits to support clients’ complete drug development programs, including:
- Geographic diversification allowing clients a more proximal location to conduct studies and increase service offerings from coast to coast
- Established experience in conducting radiolabeled studies
- Streamlined optimization and extensive expertise in biologics studies
- Access to leading physicians in numerous specialties including oncology, expansive patient populations and unique nuclear pharmacy capabilities, allowing for highly differentiated studies
- Specialized pharmacy services optimized for compounding, including radiolabeled compounds
- Extensive access to populations for targeting treatments for patients with Hepatitis C
